[NEWS] NASDAQ: It has been approved for the third time by SENS FDA. This is expected to have a positive impact on sales, and will raise the appropriate stock price to $8.
NASDAQ: It has been approved for the third time by SENS FDA. This is expected to have a positive impact on sales, and will raise the appropriate stock price to $8.
In a major breakthrough, the NASDAQ biotech company has received FDA approval for the third time for its groundbreaking new drug developed to combat a range of neurological disorders. This significant milestone is set to revolutionize the pharmaceutical industry, with experts predicting a surge in sales and a substantial increase in the company's stock price.
The newly approved drug, which has shown promising results in clinical trials, is expected to address the un...